Departments of Infectious Diseases.
Gastroenterology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
J Clin Gastroenterol. 2021 Feb 1;55(2):103-109. doi: 10.1097/MCG.0000000000001408.
There is limited evidence on the diagnostic performance of the stylet slow-pull (SP) method for endoscopic ultrasound-guided fine-needle aspiration/biopsy. The aim of this study was to compare the SP method with standard suction (SS) for endoscopic ultrasound-guided fine-needle aspiration/biopsy of solid pancreatic masses.
A computerized bibliographic search of the main databases, including PubMed, EMBASE, Cochrane Library, and Science Citation Index, was performed through February 2020. The main outcome measurements were diagnostic accuracy, cellularity, low blood contamination, adequate core tissue acquisition, and technical success rate.
Eleven studies (including 6 randomized trials) were included, with a total of 504 patients who underwent SP and 551 who underwent SS. Diagnostic accuracy was significantly superior in the SP group, compared with the SS group [odds ratio (OR)=1.60; 95% confidence interval (CI), 1.14-2.26]. The SP group had higher pooled rates of low blood contamination (OR=1.93; 95% CI, 1.29-2.87) and adequate core tissue acquisition (OR=1.91; 95% CI, 1.11-3.26) than the SS group. There was no significant difference between groups in the adequacy of cellularity (OR=0.99; 95% CI, 0.63-1.57; P=0.98) or technical success rate (OR=0.38; 95% CI, 0.13-1.15; P=0.09).
The authors provide evidence that SP is superior to SS in diagnostic accuracy, low blood contamination, and adequate core tissue acquisition, without reducing adequacy of cellularity or technical success rate.
关于超声内镜引导下细针抽吸/活检中管芯慢拉(SP)方法的诊断性能,证据有限。本研究旨在比较 SP 方法与标准抽吸(SS)在超声内镜引导下对胰腺实性肿块进行细针抽吸/活检的诊断性能。
通过计算机检索主要数据库,包括 PubMed、EMBASE、Cochrane 图书馆和科学引文索引,检索时间截至 2020 年 2 月。主要结局测量指标为诊断准确性、细胞数量、低血液污染、获得足够的核心组织和技术成功率。
共纳入 11 项研究(包括 6 项随机试验),共有 504 例患者接受 SP 检查,551 例患者接受 SS 检查。与 SS 组相比,SP 组的诊断准确性显著更高[比值比(OR)=1.60;95%置信区间(CI),1.14-2.26]。SP 组的低血液污染(OR=1.93;95% CI,1.29-2.87)和足够的核心组织获取(OR=1.91;95% CI,1.11-3.26)的汇总率高于 SS 组。两组之间的细胞数量充足率(OR=0.99;95% CI,0.63-1.57;P=0.98)或技术成功率(OR=0.38;95% CI,0.13-1.15;P=0.09)无显著差异。
作者提供的证据表明,SP 在诊断准确性、低血液污染和足够的核心组织获取方面优于 SS,而不会降低细胞数量充足率或技术成功率。